J. Moldvay (Budapest, Hungary), A. Segorbe Luis (Coimbra, Portugal)
The histological and epidemiological evaluation of patients with lung carcinoma between 1972 and 2002 in Hacettepe University Hospitals
B. Bozkurt, Z. T. Selçuk, P. Firat, A. F. Kalyoncu, M. Artvinli (Ankara, Turkey)
|  |
Lung cancer in the younger population of a local hospital
H. B. Rolke, S. Humerfelt (Kristiansand, Oslo, Norway)
| |
Clinicopathologic characteristics of lung cancer in patients 45 years of age or younger
J. Moldvay, M. Sajban, J. Strausz (Torokbalint, Hungary)
| |
Lung cancer in patients below age of 50
Z. R. Nanovic, M. Trajcevska, L. Simonovska, M. Vulovic, K. Pilovska (Skopje, Macedonia)
| |
Lung cancer in men compared with women: presentation, management, histologic characteristics and staging
G. Politis, E. Kainis, G. Zarmbis, A. Zetos, C. Chrisiotis, M. Toumbis (Athens, Greece)
| |
Screening and follow up of occult lung carcinoma (Tx) in a smoker population
M. C. De Salvo, D. R. Rey, J. A. Gonzalez (Buenos Aires, Argentina)
| |
The coexistence of lung cancer and pulmonary tuberculosis
O. N. Hatipoglu, G. Altiay, E. Tabakoglu, E. Cakir, T. Caglar (Edirne, Turkey)
| |
Cytomegalovirus (CMV) damage of the lungs associated with pulmonary tumours: is it a fortuitousness or a rule?
V. I. Shakhgildian, O. A. Tishkevich, Y. G. Parkhomenko (Moscow, Russia)
| |
The prevalence of bronchogenic lung cancer (BLC) in patients with idiopathic pneumonic fibrosis (IPF)
G. S. Vlachogeorgos, I. K. Michailidou, A. N. Xyfteri, K. S. Malagari, N. A. Karagiannidis, E. G. Kastanakis, E. T. Passalidou, V. S. Polychronopoulos (Athens, Greece)
| |
Large cell neuroendocrine carcinoma of the lung: Experience with 20 resected cases
C. Doddoli, F. Barlesi, B. Chetaille, L. Garbe, P. Thomas, R. Giudicelli, P. Fuentes (Marseille, France)
| |
HER-2/neu overexpression in patients with lung carcinoma
B. T. Ilievska, G. R. Petrusevska, S. A. Atanasova, S. S. Banev, S. Z. Talevski, S. S. Smickova (Skopje, Macedonia)
| |
Serum level of interleukin-6 as a prognostic factor in advanced nonsmall-cell lung cancer
N. Songur, F. Kalkan, N. Hizel, B. Kuru, H. Cakmak (Ankara, Turkey)
| |
Plasma D-dimer level and stage of primary lung cancer
P. Georgia, T. Vasiliki, S. Antonios, A. Dimosthenis, T. Sotirios, T. Emily, A. Ourania (Athens, Greece)
| |
Oxidant- antioxidant balance in lung cancer: is there any prognostic correlation?
F. Ulger, T. Karayilanoglu, O. Kumbasar, C. Akay, A. Sayal, N. Numanoglu (Ankara, Turkey)
| |
Prognostic value of il-6 and TNF-alfa serum concentration in advanced non-small lung cancer patients
O. I. Nicolaescu, E. D. Ciomu, D. G. Mocanescu, L. G. Ambert, M. N. Zlatev-Ionescu (Bucharest, Romania)
| |
Atrophy of bronchial epithelium as manifestation of its phenotypic lability
L. A. Naumova, I. Y. Belov (Novosibirsk, Russia)
| |